Vicky handles international operations for AWCT, coordinating investor communications, development and distribution activities, and clinical operations throughout Taiwan and Southeast Asia. Previously, as a investment principal at the Bio Fund division of Taiwania Capital, Victoria actively invested in and managed Life Science, MedTech, and Bioinformatics investments, with a mission to cultivate bio-converging technologies that drive entrepreneurial innovation and address evidence-based unmet needs. She began her career in life science entrepreneurship and has held senior executive roles in craniomaxillofacial medical devices, CAD/CAM implant & restorative dentistry, imaging-based digital health, and healthcare management across the U.S., Europe, Taiwan, China, and the ASEAN region. Victoria holds an M.S. degree in Health Policy and Management from National Taiwan University and is currently pursuing graduate studies in Strategic Innovation and Global Strategy Management at the University of Illinois Urbana-Champaign.
Tao has 30 years of experience in process engineering, manufacturing engineering and supplier engineering. Prior to joining AWCT, he worked for Intuitive Surgical, Genentech, Alexa Pharmaceuticals, Sanmina-SCI Medical Devices, and Applied Materials. He has a B.S. in mechanical engineering Shanghai Jiao Tong University and an M.S. in mechanical engineering from the University of South Carolina.
Copyright © 2025. Acoustic Wave Cell Therapy.
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use.
Tom F. Lue, MD, ScD (Hon), FACS – Co-founder;Principal Scientific Advisor.
Dr. Lue is Professor and Emil Tanagho Endowed Chair in Clinical Urology at the University of California San Francisco and medical director of the Knuppe Molecular Urology Laboratory. Dr. Lue is an internationally recognized expert on treatment of male sexual dysfunction and a pioneer in surgical methods to treat refractory ED. His research team proved that PDE5 inhibitors enhance erection in animals, providing the scientific basis for Viagra, Levitra and Cialis. He is also an expert on incontinence and developed the first animal model of female stress urinary incontinence,now used widely to study potential treatments. He is co-inventor of the sacral stimulation method of treating urge incontinence, the technology underlying Medtronic’s Interstim product line. Dr. Lue graduated with highest honors from the Kaohsiung Medical University in Taiwan and completed his urologic training at the State University of New York Downstate Medical Center. He has authored or co-authored twelve books and more than 380 publications. He is the recipient of numerous honors, including the Gold Cystoscope Award from the American Urological Association and an award for most innovative research from the American Foundation of Urologic Disease